FDA approves Alzheimer's drug to slow disease progression
Leqembi was approved by the Food and Drug Administration last month.
Stay updated with breaking news from We Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leqembi was approved by the Food and Drug Administration last month.
By the end of this year, one Nebraska Medicine doctor says he hopes the hospital system will be able to provide a new Alzheimer's drug. It's called Leqembi, and it was FDA-approved last month. It's specifically for Alzheimer's.
Dr. michael mena is the chief science officer for e-med. really good to have you here. you have been speaking to us for several months, in fact the better part of two years. last november, you wrote -- and i quote -- in "time" magazine, we need a multi-pronged public health strategy that includes a national testing plan that utilizes widespread, frequent, rapid tests to stop the spread of the virus. nothing's changed, has it, d dr. mina? why didn't this happen when people like you were calling for it? >> it's a great question, and we certainly took a vaccine-only approach for must of this year...
Medical association president dr. patrice harris, a pediatric psychiatrist and co-founder of e-med. dr. hey, i've got three kid and i've been blown away how well they have acclimated at least publicly to the last two years but we all live in persistent fear to what this is doing to them long term. do you agree with what some administration officials said that there's an epidemic of mental health challenges among children right now? >> we have certainly seen an increase in reported symptoms of depression and anxiety, an increase in thinking about no longer wanting to live in our young children ...
>> another big question, too, would there be any vaccination mandates for schools? we heard from the mayor who said at this point he is leaving that up to governor kathy hokul. joining me is the chief science officer at e-med that offers at-home testing skand he also a professor of epidemiology. dr doctor, thanks for being here. i want to start with the at-home tests because there are so many questions about whether they're accurate. i know you're a rapid test company, but i want to play for you what rochelle walensky said from the cdc, and it sounds like she's basically saying they aren't t...